From the literature, several biomarkers that patients with NAFLD and CVD share in common include: TNF-α, IL-8, IL-10, PAI-1, SREBP-1c and apoB. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.